학술논문
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
Document Type
Article
Author
Soileau, Michael J ; Aldred, Jason; Budur, Kumar; Fisseha, Nahome; Fung, Victor SC; Jeong, Anna; Kimber, Thomas E; Klos, Kevin; Litvan, Irene; O'Neill, Daniel; Robieson, Weining Z; Spindler, Meredith A; Standaert, David G; Talapala, Saritha; Vaou, Eleni Okeanis; Zheng, Hui; Facheris, Maurizio F; Hauser, Robert A
Source
In The Lancet Neurology December 2022 21(12):1099-1109
Subject
Language
ISSN
1474-4422